Empagliflozin improves cardiac function in heart failure with reduced ejection fraction independent of loading conditions

The study regarding load-independent effects of empagliflozin contribute to improved cardiac function in experimental heart failure with reduced ejection fraction is very interesting. But there are a few things we need to pay attention to.

Detalles Bibliográficos
Autores principales: Liang, Bo, Zhao, Yu-Xiu, Gu, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063753/
https://www.ncbi.nlm.nih.gov/pubmed/32156272
http://dx.doi.org/10.1186/s12933-020-01004-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063753/
https://www.ncbi.nlm.nih.gov/pubmed/32156272
http://dx.doi.org/10.1186/s12933-020-01004-9

Ejemplares similares